Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "thomas amort"

Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches
EuroInvestor

Novartis Pharmaceuticals launches the first app for visually i...

New features of the ViaOpta apps, previously available for iPhone and Android TM mobile phones, are also available to enhance the daily lives of people with visual impairments These apps foster independence through step-by-step navigation and ... Fierce Biotech IT, 20 hours ago
[x]  
Seeking Alpha

Precision Castparts: Compounder, Margin Of Safety, Long-Term Upside

Jul. 2, 2015 1:04 PM ET | About: Precision Castparts Corp. (PCP) by: Summary Precision Castparts has fallen out of favor due to short term issues such as lower revenue from oil+gas counter-parties, an incident at their plant, and exiting of a ...
 Seeking Alpha2 days ago
Canadian Business Journal

Magellan Announces Conversion of Revolving Loan Into Term Loan

) - Magellan Petroleum Corporation ( NASDAQ: MPET ) ("Magellan" or the "Company") today announced the amendment of the senior secured revolving loan facility (the "Revolving Loan Facility"), which Nautilus Poplar LLC ("Nautilus"), a wholly owned ...
 CEOWorld Magazine4 days ago MAGELLAN PETROLEUM : Announces Conversion of Revolving Loan Into Term Loan  4 Traders4 days ago
[x]  

The Super Powered Rule of Stare Decisis Defeats Spider Man

The Supreme Court of the United States, in a 6-3 decision, left undisturbed the rule from Brulotte v. Thys Co . (1964), invokingstare decisisand rejecting arguments seeking to overturn the rule barring patent royalty agreements that obligate payment ...
 National Law Review4 days ago The 'Super Powered' Rule of Stare Decisis Defeats Spider Man  National Law Review1 week ago
EuroInvestor

Alcon receives European Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery

Novartis International AG / Alcon receives European Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely ...
 EuroInvestor5 days ago NOVARTIS : Alcon receives European Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery  4 Traders5 days ago
[x]  

DGAP-News: euromicron AG confirms forecast despite slow start to fiscal year 2015

- Group sales remain stable at EUR 74.6 million - EBITDA margin of 1.0% mainly due to one-time effects of severance payments - Correction of previous year's comparative figures for 2014 in the interim financial statements for 2015 - ...
 Wallstreet Online6 days ago
EuroInvestor

NOVARTIS : deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.

Novartis International AG / Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc. . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this ...
 4 Traders1 week ago Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.  Swiss Life Sciences Database1 week ago
[x]  

GLOBE TRADE CENTRE : GTC finalized debt restructuring of its Romanian subsidiaries

Globe Trade Centre S.A. ("GTC") successfully restructured the loan agreements of its Romanian subsidiaries with the European Bank for Reconstruction and Development ("EBRD"). On 26 June 2015, GTC signed the agreement with EBRD for the ...
 4 Traders1 week ago GTC finalized debt restructuring of its Romanian subsidiaries  Noodls1 week ago
EuroInvestor

Novartis announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients

Novartis International AG / Novartis announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is ...
 EuroInvestor1 week ago NOVARTIS : announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients  4 Traders1 week ago
[x]  

Kimble v. Marvel: Supreme Court affirms unenforceability of contract provisions that run royalties beyond patent's term: 3 takeaways

The Supreme Court this week upheld a long-standing precedent that restricts the ability of a patent holder to charge a royalty beyond the term of a patent. In a 6-3 decision, the court in Kimble v. Marvel Entertainment declined to overrule Brulotte ...
 JD Supra1 week ago Litigation Alert: Even Spider-Man Can't Defeat Ban on Post-Patent Expiration Royalties  JD Supra1 week ago Supreme Court Affirms Ban on Patent Royalties After Patent Expiration  National Law Review1 week ago The Finite Life of a Patent Upheld: No Royalties After Expiration  JD Supra1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less